Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

MBRXMBRX
3 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in MOLECULIN BIOTECH INC

GEODE CAPITAL MANAGEMENT, LLC holds 47,252 shares of MBRX (MOLECULIN BIOTECH INC), worth $131,832 as of 2026-Q2. The position was increased (+46.2% shares).

Current Value

$131,832

Current Shares

47,252

Total Value Change

+$81,726

Total Shares Change

+32,114

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
47,252
+46.2%
$131,8320.0%$2.79
21
2026-Q1
Increased
32,329
+113.6%
$74,0330.0%$2.27
23
2025-Q4
New
15,138
-
$50,1060.0%$3.32
31

Other major holders of MBRX: VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, VANGUARD FIDUCIARY TRUST CO, JANE STREET GROUP, LLC, XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used